Diego Hidalgo-Mazzei

Dr. Diego Hidalgo-Mazzei


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2016 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
MGMarina Garriga
Marina Garriga
IPIsabella Pacchiarotti
Isabella Pacchiarotti
SKSiegfried Kasper
Siegfried Kasper
SZScott L. Zeller
Scott L. Zeller
MAMichael H. Allen
Michael H. Allen
Eduard VietaEduard Vieta
Eduard Vieta
Psychomotor agitation is associated with different psychiatric conditions and represents an important issue in psychiatry. Current recommendations on agitation in psychiatry are not univocal. Actually, an improper assessment and management may result in unnecessary coercive or sedative treatments. A thorough and balanced review plus an expert consensus can guide assessment and treatment decisions. An expert task force iteratively developed consensus using the Delphi method. Initial survey items were based on systematic review of the literature. Subsequent surveys included new, re-worded or re-rated items. Out of 2175 papers assessing psychomotor agitation, 124 were included in the review. Each component was assigned a level of evidence. Integrating the evidence and the experience of the task force members, a consensus was reached on 22 statements on this topic. Recommendations on the assessment of agitation emphasise the importance of identifying any possible medical cause. For its management, experts agreed in considering verbal de-escalation and environmental modification techniques as first choice, considering physical restraint as a last resort strategy. Regarding pharmacological treatment, the "ideal" medication should calm without over-sedate. Generally, oral or inhaled formulations should be preferred over i.m. routes in mildly agitated patients. Intravenous treatments should be avoided.

1 August 2016 in Journal of Affective Disorders
Verified
Journal Article
Closed access
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
AMAinoa Mateu
Ainoa Mateu
MRMaría Reinares
María Reinares
AMAndrea Murru
Andrea Murru
CBCaterina del Mar Bonnín
Caterina del Mar Bonnín
FCFrancesc Colom
Francesc Colom

1 August 2017 in International Journal of Bipolar Disorders
Verified
Journal Article
Open access
PDF file
LTLeonardo Tondo
Leonardo Tondo
MAMaria Abramowicz
Maria Abramowicz
MAMartin Alda
Martin Alda
MBMichael Bauer
Michael Bauer
ABAlberto Bocchetta
Alberto Bocchetta
RBRoss Baldessarini
Ross Baldessarini
Concerns about potential adverse effects of long-term exposure to lithium as a mood-stabilizing treatment notably include altered renal function. However, the incidence of severe renal dysfunction; rate of decline over time; effects of lithium dose, serum concentration, and duration of treatment; relative effects of lithium exposure vs. aging; and contributions of sex and other factors all remain unclear. Accordingly, we acquired data from 12 collaborating international sites and 312 bipolar disorder patients (6142 person-years, 2669 assays) treated with lithium carbonate for 8–48 (mean 18) years and aged 20–89 (mean 56) years. We evaluated changes of estimated glomerular filtration rate (eGFR) as well as serum creatinine, urea–nitrogen, and glucose concentrations, white blood cell count, and body-mass index, and tested associations of eGFR with selected factors, using standard bivariate contrasts and regression modeling. Overall, 29.5% of subjects experienced at least one low value of eGFR ( 55; risk of ≥2 low values was 18.1%; none experienced end-stage renal failure. eGFR declined by 0.71%/year of age and 0.92%/year of treatment, both by 19% more among women than men. Mean serum creatinine increased from 0.87 to 1.17 mg/dL, BUN from 23.7 to 33.1 mg/dL, glucose from 88 to 122 mg/dL, and BMI from 25.9 to 26.6 kg/m2. By multivariate regression, risk factors for declining eGFR ranked: longer lithium treatment, lower lithium dose, higher serum lithium concentration, older age, and medical comorbidity. Later low eGFR was also predicted by lower initial eGFR, and starting lithium at age ≥ 40 years. Control data for age-matched subjects not exposed to lithium were lacking. Long-term lithium treatment was associated with gradual decline of renal functioning (eGFR) by about 30% more than that was associated with aging alone. Risk of subnormal eGFR was from 18.1% (≥2 low values) to 29.5% (≥1 low value), requiring about 30 years of exposure. Additional risk factors for low eGFR were higher serum lithium level, longer lithium treatment, lower initial eGFR, and medical comorbidity, as well as older age.

1 February 2016 in Clinical Psychology Review
Verified
Journal Article
Closed access
MRM. Reinares
M. Reinares
CBC.M. Bonnín
C.M. Bonnín
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
JSJose Sánchez-Moreno
Jose Sánchez-Moreno
FCFrancesc Colom
Francesc Colom
Eduard VietaEduard Vieta
Eduard Vieta

1 December 2018 in Journal of Affective Disorders
Verified
Journal Article
Open access
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
MRMaría Reinares
María Reinares
AMAinoa Mateu
Ainoa Mateu
VNViktoriya Nikolova
Viktoriya Nikolova
CBCaterina del Mar Bonnín
Caterina del Mar Bonnín
FCFrancesc Colom
Francesc Colom
Few evidence-based mental health apps are widely available to patients and, conversely, many of the available apps have not been appropriately evaluated. Given that the ultimate goal is to scale-up and open internet-based platforms (IBP), it is crucial to appropriately evaluate their real-world feasibility beforehand. We aimed to evaluate the implementation feasibility of a smartphone-based psychoeducational programme for bipolar disorder, exploring its long-term retention, usability, perceived helpfulness and satisfaction, alongside its impact on secondary health outcomes. Participants were recruited via the project website after completing an online screening questionnaire. They were requested to complete web-based questionnaires before using the app and after 6 months of use which included sociodemographic, illness and treatment variables, the world health organisation-five well-being index (WHO-5) and the short form health survey (SF-36). The follow-up questionnaires also contained satisfaction and usefulness questions. 201 participants took part in the study. According to their retention, 66.2% of the participants were classified as noncompleters and 33.8% as completers. The only predictor significantly associated with higher odds of retention was older age (OR = 1.021, p < 0.001). 62% of the users reported they were satisfied with the programme with a higher percentage among completers. Who-5 baseline and follow-up scores showed a significant improvement as well as 6 out of 8 domains of the SF-36. Screening and outcome measures were administered using exclusively self-reported online methods. The 6-month attrition rate of the programme was high. Positive outcomes regarding satisfaction were found predominantly among completers. The optimal dosage and retention of IBP mental health programmes remain challenging issues that need further research.

27 July 2020 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
AMAnjum Memon
Anjum Memon
IRImogen Rogers
Imogen Rogers
SFSophie M. D. D. Fitzsimmons
Sophie M. D. D. Fitzsimmons
BCBen Carter
Ben Carter
RSRebecca Strawbridge
Rebecca Strawbridge
Allan YoungAllan Young
Allan Young
Background: The prevalence of mental health conditions and national suicide rates are increasing in many countries. Lithium is widely and effectively used in pharmacological doses for the treatment and prevention of manic/depressive episodes, stabilising mood and reducing the risk of suicide. Since the 1990s, several ecological studies have tested the hypothesis that trace doses of naturally occurring lithium in drinking water may have a protective effect against suicide in the general population.Aims: To synthesise the global evidence on the association between lithium levels in drinking water and suicide mortality rates.Method: The MEDLINE, Embase, Web of Science and PsycINFO databases were searched to identify eligible ecological studies published between 1 January 1946 and 10 September 2018. Standardised regression coefficients for total (i.e. both genders combined), male and female suicide mortality rates were extracted and pooled using random-effects meta-analysis. The study was registered with PROSPERO (CRD42016041375).Results: The literature search identified 415 articles; of these, 15 ecological studies were included in the synthesis. The random-effects meta-analysis showed a consistent protective (or inverse) association between lithium levels/concentration in publicly available drinking water and total (pooled β = −0.27, 95% CI −0.47 to −0.08; P = 0.006, I2 = 83.3%), male (pooled β = −0.26, 95% CI −0.56 to 0.03; P = 0.08, I2 = 91.9%) and female (pooled β = −0.13, 95% CI −0.24 to −0.02; P = 0.03, I2 = 28.5%) suicide mortality rates. A similar protective association was observed in the six studies included in the narrative synthesis, and subgroup meta-analyses based on the higher/lower suicide mortality rates and lithium levels/concentration.Conclusions: This synthesis of ecological studies, which are subject to the ecological fallacy/bias, supports the hypothesis that there is a protective (or inverse) association between lithium intakes from public drinking water and suicide mortality at the population level. Naturally occurring lithium in drinking water may have the potential to reduce the risk of suicide and may possibly help in mood stabilisation, particularly in populations with relatively high suicide rates and geographical areas with a greater range of lithium concentration in the drinking water. All the available evidence suggests that randomised community trials of lithium supplementation of the water supply might be a means of testing the hypothesis, particularly in communities (or settings) with demonstrated high prevalence of mental health conditions, violent criminal behaviour, chronic substance misuse and risk of suicide.